Angiogenesis and Long-term Bone and Joint Allotransplant Survival
血管生成和长期骨和关节同种异体移植存活
基本信息
- 批准号:9440959
- 负责人:
- 金额:$ 44.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AllogenicAllograftingAnimal ModelAnimalsAreaAutologousAutologous TransplantationBiomechanicsBloodBlood CirculationBlood VesselsBlood capillariesBlood flowBone remodelingChimerismDefectExcisionFailureFamily suidaeFractureGenerationsGoalsGrowth Factor GeneHLA AntigensHaplotypesImmune responseImmunosuppressionImplantInfectionJointsKnowledgeLifeLimb SalvageLimb structureMeasuresMechanicsMediatingMethodsMiniature SwineModelingMorbidity - disease rateMorphologyNatural regenerationNecrosisNeoplasmsOperative Surgical ProceduresOryctolagus cuniculusOsteocytesOsteogenesisPharmaceutical PreparationsPharmacotherapyProblem SolvingProcessProsthesisRattusResearchShapesStress FracturesTestingTherapeutic EffectTimeTissue ViabilityTransduction GeneTranslatingTransplantationTraumaUnited StatesVascular Endothelial CellVascular Endothelial Growth FactorsVascular EndotheliumVascular blood supplyVascular remodelingViralallogenic bone transplantationallotransplantangiogenesisbonebone circulationbone healingbone lossbone strengthclinical applicationcongenital anomalydensitygene therapyhealingimmunoregulationimplantationimprovednovelperipheral bloodprimary bone cancerpublic health relevancereconstructiontherapeutic angiogenesistumor
项目摘要
DESCRIPTION (provided by applicant): More than 3000 limb-sparing surgeries are performed annually in the United States to reconstruct segmental loss of bone resulting from treatment of neoplasm, infection, trauma or congenital anomaly. Current limb salvage reconstructive options have significant morbidity and frequent complications including prosthetic loosening and mechanical failures, as well as late stress fracture, infection and nonunion of bone allografts. A better solution to this difficult problem is required. The ability to transplant living allogeneic one, or alternatively, to revitalize cryopreserved bone allografts (CBAs) whose shape closely matches missing bone morphology potentially provides both the immediate stability needed for limb function as well as the vascularity needed to maintain or restore osteocyte viability. The result may be the same healing and remodeling potential as autogenous living bone. We have demonstrated the use of angiogenesis from autogenous vessels to provide a neoangiogenic circulation and promote vital, remodeling of bone. This may be accomplished in bone vascularized composite allotransplants (VCA) without need for long-term immune modulation. Instead, only 2 weeks of drug immunosuppression is used, sufficient to permit generation of the neoangiogenic circulation. The same process may revitalize cryopreserved bone allografts in the same rat and rabbit models. The important next steps require the use of a large animal model if our decade of small animal study is to be successfully translated into clinical applications. We propose to use Yucatan miniature swine for this purpose, orthotopically reconstructing segmental tibial defects with allogeneic bone. We will test if bone VCA and CBA segments will demonstrate enhanced bone circulation and remodeling potential, when surgically revascularized with implanted autogenous vessels. We will investigate the interplay of angiogenesis and systemic immune responses, and ask how they influence allograft segmental revitalization, bone remodeling and biomechanics. We will further ask if vascular endothelial growth factor (VEGF) delivery provided by VEGF gene transduction of vascular endothelial cells may further improve the results in both cryopreserved bone allografts (CBA) and bone VCA reconstruction.
描述(由申请人提供):美国每年进行超过3000例肢体保留手术,以重建因治疗肿瘤、感染、创伤或先天性异常而导致的节段性骨缺损。目前的保肢重建选择有显着的发病率和频繁的并发症,包括假体松动和机械故障,以及后期应力骨折,感染和骨移植不愈合。需要更好地解决这个难题。移植活体同种异体骨的能力,或者使形状与缺失骨形态紧密匹配的冷冻保存骨同种异体移植物(CBA)恢复活力的能力,可能提供肢体功能所需的即时稳定性以及维持或恢复骨细胞活力所需的血管供应。其结果可能是相同的愈合和重建潜力的自体活骨。我们已经证明了利用自体血管的血管生成来提供新血管生成循环并促进骨的重要重塑。这可以在骨血管化复合同种异体移植物(VCA)中完成,而不需要长期的免疫调节。相反,仅使用2周的药物免疫抑制,足以允许新血管生成循环的产生。在相同的大鼠和兔模型中,相同的过程可以使冷冻保存的同种异体骨移植物恢复活力。如果我们十年的小动物研究要成功地转化为临床应用,接下来的重要步骤需要使用大型动物模型。我们建议使用尤卡坦小型猪,原位重建节段性胫骨缺损与同种异体骨。我们将测试当用植入的自体血管进行手术血运重建时,骨VCA和CBA节段是否会表现出增强的骨循环和重塑潜力。我们将探讨血管生成和全身免疫反应的相互作用,并询问它们如何影响同种异体骨节段性再生,骨重建和生物力学。我们将进一步询问通过血管内皮细胞的VEGF基因转导提供的血管内皮生长因子(VEGF)递送是否可以进一步改善冷冻保存的骨同种异体移植物(CBA)和骨VCA重建的结果。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Repopulation of vascularized bone allotransplants with recipient-derived cells: detection by laser capture microdissection and real-time PCR.
- DOI:10.1002/jor.20915
- 发表时间:2009-11
- 期刊:
- 影响因子:2.8
- 作者:Pelzer, Michael;Larsen, Mikko;Friedrich, Patricia F.;Aleff, Ross A.;Bishop, Allen T.
- 通讯作者:Bishop, Allen T.
Fibroblast growth factor-2 and vascular endothelial growth factor mediated augmentation of angiogenesis and bone formation in vascularized bone allotransplants.
成纤维细胞生长因子-2 和血管内皮生长因子介导血管化同种异体骨移植中血管生成和骨形成的增强。
- DOI:10.1002/micr.22221
- 发表时间:2014
- 期刊:
- 影响因子:2.1
- 作者:Larsen,Mikko;Willems,WouterF;Pelzer,Michael;Friedrich,PatriciaF;Dadsetan,Mahrokh;Bishop,AllenT
- 通讯作者:Bishop,AllenT
Augmentation of surgical angiogenesis in vascularized bone allotransplants with host-derived a/v bundle implantation, fibroblast growth factor-2, and vascular endothelial growth factor administration.
- DOI:10.1002/jor.21098
- 发表时间:2010-08
- 期刊:
- 影响因子:2.8
- 作者:Larsen, Mikko;Willems, Wouter F.;Pelzer, Michael;Friedrich, Patricia F.;Yaszemski, Michael J.;Bishop, Allen T.
- 通讯作者:Bishop, Allen T.
Vascularized bone transplant chimerism mediated by vascular endothelial growth factor.
由血管内皮生长因子介导的血管化骨移植嵌合体。
- DOI:10.1002/micr.22300
- 发表时间:2015
- 期刊:
- 影响因子:2.1
- 作者:Willems,WouterF;Larsen,Mikko;Friedrich,PatriciaF;Bishop,AllenT
- 通讯作者:Bishop,AllenT
Cell lineage in vascularized bone transplantation.
- DOI:10.1002/micr.22147
- 发表时间:2014-01
- 期刊:
- 影响因子:2.1
- 作者:Willems, Wouter F.;Larsen, Mikko;Friedrich, Patricia F.;Bishop, Allen T.
- 通讯作者:Bishop, Allen T.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALLEN T BISHOP其他文献
ALLEN T BISHOP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALLEN T BISHOP', 18)}}的其他基金
Angiogenesis and Long-term Bone and Joint Allotransplant Survival
血管生成和长期骨和关节同种异体移植存活
- 批准号:
8998928 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-Term Bone Allograft Survival
血管生成和同种异体骨移植的长期存活
- 批准号:
6847852 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-term Bone and Joint Allotransplant Survival
血管生成和长期骨和关节同种异体移植存活
- 批准号:
7645626 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-term Bone and Joint Allotransplant Survival
血管生成和长期骨和关节同种异体移植存活
- 批准号:
9207420 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-term Bone and Joint Allotransplant Survival
血管生成和长期骨和关节同种异体移植存活
- 批准号:
8274356 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-Term Bone Allograft Survival
血管生成和同种异体骨移植的长期存活
- 批准号:
7201632 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-term Bone and Joint Allotransplant Survival
血管生成和长期骨和关节同种异体移植存活
- 批准号:
7858279 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-Term Bone Allograft Survival
血管生成和同种异体骨移植的长期存活
- 批准号:
6596312 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-Term Bone Allograft Survival
血管生成和同种异体骨移植的长期存活
- 批准号:
7056814 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
Angiogenesis and Long-term Bone and Joint Allotransplant Survival
血管生成和长期骨和关节同种异体移植存活
- 批准号:
7522876 - 财政年份:2003
- 资助金额:
$ 44.08万 - 项目类别:
相似海外基金
Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
- 批准号:
26462277 - 财政年份:2014
- 资助金额:
$ 44.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
- 批准号:
8344380 - 财政年份:2012
- 资助金额:
$ 44.08万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7878675 - 财政年份:2009
- 资助金额:
$ 44.08万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7677758 - 财政年份:2009
- 资助金额:
$ 44.08万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7466112 - 财政年份:2008
- 资助金额:
$ 44.08万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8010394 - 财政年份:2008
- 资助金额:
$ 44.08万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8208131 - 财政年份:2008
- 资助金额:
$ 44.08万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7575273 - 财政年份:2008
- 资助金额:
$ 44.08万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7765518 - 财政年份:2008
- 资助金额:
$ 44.08万 - 项目类别: